Clinical Trial

Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Eydie Miller Ellis, Michael S Berlin, Caroline L Ward, John A Sharpe, Alam Jamil, Alon Harris

British Journal of Ophthalmology Jun 2017, 101 (6) 796-800; DOI: 10.1136/bjophthalmol-2016-309023
Safety and efficacy of a hydroxypropyl guar/polyethylene glycol/propylene glycol-based lubricant eye-drop in patients with dry eye
Marc Labetoulle, Elisabeth M Messmer, Pierre-Jean Pisella, Abayomi Ogundele, Christophe Baudouin

British Journal of Ophthalmology Apr 2017, 101 (4) 487-492; DOI: 10.1136/bjophthalmol-2016-308608
Intraoperative aberrometry-based aphakia refraction in patients with cataract: status and options
Jan O Huelle, Vasyl Druchkiv, Nabil E Habib, Gisbert Richard, Toam Katz, Stephan J Linke

British Journal of Ophthalmology Feb 2017, 101 (2) 97-102; DOI: 10.1136/bjophthalmol-2015-307594
Objective and subjective visual quality after implantation of all optic zone diffractive multifocal intraocular lenses: a prospective, case-control observational study
Tianyu Chen, Fang Yu, Huayou Lin, Yinying Zhao, Pingjun Chang, Lei Lin, Qi Chen, Qian Zheng, Yun-e Zhao, Fan Lu, Jin Li

British Journal of Ophthalmology Nov 2016, 100 (11) 1530-1535; DOI: 10.1136/bjophthalmol-2015-307135
Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes
Ester Carreño, Tanya Moutray, Konstantinos Fotis, Richard W J Lee, Andrew D Dick, Adam H Ross, Clare Bailey

British Journal of Ophthalmology Sep 2016, 100 (9) 1221-1226; DOI: 10.1136/bjophthalmol-2015-307806
Early versus delayed intravitreal betamethasone as an adjuvant in the treatment of presumed postoperative endophthalmitis: a randomised trial
Philippe Koehrer, Alain M Bron, Christophe Chiquet, Gilles Thuret, Bernard Delbosc, Jean-Paul Berrod, Tristan Bourcier, Arnaud Sauer, Lysiane Jonval, Philippe D'Athis, Catherine Creuzot-Garcher

British Journal of Ophthalmology Aug 2016, 100 (8) 1076-1080; DOI: 10.1136/bjophthalmol-2015-307063
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial
Hemal Mehta, Samantha Fraser-Bell, Aaron Yeung, Anna Campain, Lyndell L Lim, Godfrey J Quin, Ian L McAllister, Pearse A Keane, Mark C Gillies

British Journal of Ophthalmology Jul 2016, 100 (7) 1000-1004; DOI: 10.1136/bjophthalmol-2015-307797
Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery
Marc Labetoulle, Oliver Findl, François Malecaze, Jorge Alió, Béatrice Cochener, Conceição Lobo, Sihem Lazreg, Dahbia Hartani, Joseph Colin, Marie-José Tassignon, Anders Behndig

British Journal of Ophthalmology Jul 2016, 100 (7) 976-985; DOI: 10.1136/bjophthalmol-2015-307587
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study
Christian Prünte, Franck Fajnkuchen, Sajjad Mahmood, Federico Ricci, Katja Hatz, Jan Studnička, Vladimir Bezlyak, Soumil Parikh, William John Stubbings, Andreas Wenzel, João Figueira, and the RETAIN Study Group

British Journal of Ophthalmology Jun 2016, 100 (6) 787-795; DOI: 10.1136/bjophthalmol-2015-307249
Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
Ronald P Danis, Srinivas Sadda, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup

British Journal of Ophthalmology Jun 2016, 100 (6) 796-801; DOI: 10.1136/bjophthalmol-2015-306823

Main menu

Clinical Trial

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Clinical Trial

Pages